カテゴリー： 世界, 医療/バイオ, LP Information

世界の薬剤溶出性ステント市場予測 2023年-2029年

【英語タイトル】Global Drug-Eluting Stents Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4580）・商品コード：LP23MY4580
・発行会社（調査会社）：LP Information
・発行日：2023年5月
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の薬剤溶出性ステント市場」は、過去の販売実績から2022年の世界の薬剤溶出性ステントの総販売量を検討し、2023年から2029年の予測される薬剤溶出性ステントの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の薬剤溶出性ステントの市場規模を掲載し、XXX百万米ドル規模の世界の薬剤溶出性ステント市場の詳細な分析を提供します。本インサイトレポートは、世界の薬剤溶出性ステント業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の薬剤溶出性ステント市場における各社の独自のポジションをより深く理解するために、薬剤溶出性ステント製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の薬剤溶出性ステント市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。薬剤溶出性ステントの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。薬剤溶出性ステントの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。薬剤溶出性ステントのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

薬剤溶出性ステントの世界主要メーカーとしては、Boston Scientific、 Medtronic, Inc.、 Abbott、 Lepu Medical、 MicroPort Scientific Corporation、 Cook Medical、 Terumo、 Biosensors International、 Balton、 AlviMedica Medical Technologies、 Biotronik、 Shandong JW Medical、 Sino Medical、 Beijing AMSINO、 Liaoning Biomedical Materials R&D Center Co.(LBC)などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の薬剤溶出性ステント市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では薬剤溶出性ステント市場をセグメンテーションし、種類別 (ラパマイシン、パクリタキセル、エベロリムス、その他)、用途別 (狭心症、心筋梗塞)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ラパマイシン、パクリタキセル、エベロリムス、その他

・用途別区分：狭心症、心筋梗塞

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の薬剤溶出性ステント市場の10年間の市場状況・展望は？
・世界および地域別に見た薬剤溶出性ステント市場成長の要因は何か？
・薬剤溶出性ステントの市場機会はエンドマーケットの規模によってどのように変化するのか？
・薬剤溶出性ステントのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：薬剤溶出性ステントの年間販売量2018-2029、地域別現状・将来分析
・薬剤溶出性ステントの種類別セグメント：ラパマイシン、パクリタキセル、エベロリムス、その他
・薬剤溶出性ステントの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・薬剤溶出性ステントの用途別セグメント：狭心症、心筋梗塞
・薬剤溶出性ステントの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の薬剤溶出性ステント市場
・企業別のグローバル薬剤溶出性ステント市場データ：2018-2023年の年間販売量、市場シェア
・企業別の薬剤溶出性ステントの年間売上：2018-2023年の売上、市場シェア
・企業別の薬剤溶出性ステント販売価格
・主要企業の薬剤溶出性ステント生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

薬剤溶出性ステントの地域別レビュー
・地域別の薬剤溶出性ステント市場規模2018-2023：年間販売量、売上
・主要国別の薬剤溶出性ステント市場規模2018-2023：年間販売量、売上
・南北アメリカの薬剤溶出性ステント販売の成長
・アジア太平洋の薬剤溶出性ステント販売の成長
・ヨーロッパの薬剤溶出性ステント販売の成長
・中東・アフリカの薬剤溶出性ステント販売の成長

南北アメリカ市場
・南北アメリカの国別の薬剤溶出性ステント販売量、売上（2018-2023）
・南北アメリカの薬剤溶出性ステントの種類別販売量
・南北アメリカの薬剤溶出性ステントの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の薬剤溶出性ステント販売量、売上（2018-2023）
・アジア太平洋の薬剤溶出性ステントの種類別販売量
・アジア太平洋の薬剤溶出性ステントの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の薬剤溶出性ステント販売量、売上（2018-2023）
・ヨーロッパの薬剤溶出性ステントの種類別販売量
・ヨーロッパの薬剤溶出性ステントの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の薬剤溶出性ステント販売量、売上（2018-2023）
・中東・アフリカの薬剤溶出性ステントの種類別販売量
・中東・アフリカの薬剤溶出性ステントの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・薬剤溶出性ステントの製造コスト構造分析
・薬剤溶出性ステントの製造プロセス分析
・薬剤溶出性ステントの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・薬剤溶出性ステントの主要なグローバル販売業者
・薬剤溶出性ステントの主要なグローバル顧客

地域別の薬剤溶出性ステント市場予測レビュー
・地域別の薬剤溶出性ステント市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・薬剤溶出性ステントの種類別市場規模予測
・薬剤溶出性ステントの用途別市場規模予測

主要企業分析
Boston Scientific、 Medtronic, Inc.、 Abbott、 Lepu Medical、 MicroPort Scientific Corporation、 Cook Medical、 Terumo、 Biosensors International、 Balton、 AlviMedica Medical Technologies、 Biotronik、 Shandong JW Medical、 Sino Medical、 Beijing AMSINO、 Liaoning Biomedical Materials R&D Center Co.(LBC)
・企業情報
・薬剤溶出性ステント製品
・薬剤溶出性ステント販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.
LPI (LP Information)’ newest research report, the “Drug-Eluting Stents Industry Forecast” looks at past sales and reviews total world Drug-Eluting Stents sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug-Eluting Stents sales for 2023 through 2029. With Drug-Eluting Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Eluting Stents industry.
This Insight Report provides a comprehensive analysis of the global Drug-Eluting Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Eluting Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug-Eluting Stents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Eluting Stents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Eluting Stents.
The global Drug-Eluting Stents market size is projected to grow from US$ 5824.5 million in 2022 to US$ 7476.2 million in 2029; it is expected to grow at a CAGR of 7476.2 from 2023 to 2029.
North America dominated the global Drug Eluting Stent Market with a revenue share of 37% in 2017. The dominance of the region was majorly attributed to stringent regulatory guidelines for medical device manufacturing and approval. In addition, the reimbursement coverage coupled with a high incidence rate of artery diseases is anticipated to augment the market growth in North America.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Eluting Stents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Rapamycin
Paclitaxel
Everolimus
Others
Segmentation by application
Angina Pectoris
Myocardial Infarction
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co.(LBC)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Drug-Eluting Stents market?
What factors are driving Drug-Eluting Stents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Eluting Stents market opportunities vary by end market size?
How does Drug-Eluting Stents break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug-Eluting Stents Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug-Eluting Stents by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug-Eluting Stents by Country/Region, 2018, 2022 & 2029
2.2 Drug-Eluting Stents Segment by Type
2.2.1 Rapamycin
2.2.2 Paclitaxel
2.2.3 Everolimus
2.2.4 Others
2.3 Drug-Eluting Stents Sales by Type
2.3.1 Global Drug-Eluting Stents Sales Market Share by Type (2018-2023)
2.3.2 Global Drug-Eluting Stents Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug-Eluting Stents Sale Price by Type (2018-2023)
2.4 Drug-Eluting Stents Segment by Application
2.4.1 Angina Pectoris
2.4.2 Myocardial Infarction
2.5 Drug-Eluting Stents Sales by Application
2.5.1 Global Drug-Eluting Stents Sale Market Share by Application (2018-2023)
2.5.2 Global Drug-Eluting Stents Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug-Eluting Stents Sale Price by Application (2018-2023)
3 Global Drug-Eluting Stents by Company
3.1 Global Drug-Eluting Stents Breakdown Data by Company
3.1.1 Global Drug-Eluting Stents Annual Sales by Company (2018-2023)
3.1.2 Global Drug-Eluting Stents Sales Market Share by Company (2018-2023)
3.2 Global Drug-Eluting Stents Annual Revenue by Company (2018-2023)
3.2.1 Global Drug-Eluting Stents Revenue by Company (2018-2023)
3.2.2 Global Drug-Eluting Stents Revenue Market Share by Company (2018-2023)
3.3 Global Drug-Eluting Stents Sale Price by Company
3.4 Key Manufacturers Drug-Eluting Stents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Eluting Stents Product Location Distribution
3.4.2 Players Drug-Eluting Stents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Drug-Eluting Stents by Geographic Region
4.1 World Historic Drug-Eluting Stents Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug-Eluting Stents Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug-Eluting Stents Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug-Eluting Stents Market Size by Country/Region (2018-2023)
4.2.1 Global Drug-Eluting Stents Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug-Eluting Stents Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug-Eluting Stents Sales Growth
4.4 APAC Drug-Eluting Stents Sales Growth
4.5 Europe Drug-Eluting Stents Sales Growth
4.6 Middle East & Africa Drug-Eluting Stents Sales Growth
5 Americas
5.1 Americas Drug-Eluting Stents Sales by Country
5.1.1 Americas Drug-Eluting Stents Sales by Country (2018-2023)
5.1.2 Americas Drug-Eluting Stents Revenue by Country (2018-2023)
5.2 Americas Drug-Eluting Stents Sales by Type
5.3 Americas Drug-Eluting Stents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Eluting Stents Sales by Region
6.1.1 APAC Drug-Eluting Stents Sales by Region (2018-2023)
6.1.2 APAC Drug-Eluting Stents Revenue by Region (2018-2023)
6.2 APAC Drug-Eluting Stents Sales by Type
6.3 APAC Drug-Eluting Stents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drug-Eluting Stents by Country
7.1.1 Europe Drug-Eluting Stents Sales by Country (2018-2023)
7.1.2 Europe Drug-Eluting Stents Revenue by Country (2018-2023)
7.2 Europe Drug-Eluting Stents Sales by Type
7.3 Europe Drug-Eluting Stents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug-Eluting Stents by Country
8.1.1 Middle East & Africa Drug-Eluting Stents Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug-Eluting Stents Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug-Eluting Stents Sales by Type
8.3 Middle East & Africa Drug-Eluting Stents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Eluting Stents
10.3 Manufacturing Process Analysis of Drug-Eluting Stents
10.4 Industry Chain Structure of Drug-Eluting Stents
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Eluting Stents Distributors
11.3 Drug-Eluting Stents Customer
12 World Forecast Review for Drug-Eluting Stents by Geographic Region
12.1 Global Drug-Eluting Stents Market Size Forecast by Region
12.1.1 Global Drug-Eluting Stents Forecast by Region (2024-2029)
12.1.2 Global Drug-Eluting Stents Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Eluting Stents Forecast by Type
12.7 Global Drug-Eluting Stents Forecast by Application
13 Key Players Analysis
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Drug-Eluting Stents Product Portfolios and Specifications
13.1.3 Boston Scientific Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Medtronic, Inc.
13.2.1 Medtronic, Inc. Company Information
13.2.2 Medtronic, Inc. Drug-Eluting Stents Product Portfolios and Specifications
13.2.3 Medtronic, Inc. Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic, Inc. Main Business Overview
13.2.5 Medtronic, Inc. Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Drug-Eluting Stents Product Portfolios and Specifications
13.3.3 Abbott Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Lepu Medical
13.4.1 Lepu Medical Company Information
13.4.2 Lepu Medical Drug-Eluting Stents Product Portfolios and Specifications
13.4.3 Lepu Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lepu Medical Main Business Overview
13.4.5 Lepu Medical Latest Developments
13.5 MicroPort Scientific Corporation
13.5.1 MicroPort Scientific Corporation Company Information
13.5.2 MicroPort Scientific Corporation Drug-Eluting Stents Product Portfolios and Specifications
13.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MicroPort Scientific Corporation Main Business Overview
13.5.5 MicroPort Scientific Corporation Latest Developments
13.6 Cook Medical
13.6.1 Cook Medical Company Information
13.6.2 Cook Medical Drug-Eluting Stents Product Portfolios and Specifications
13.6.3 Cook Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cook Medical Main Business Overview
13.6.5 Cook Medical Latest Developments
13.7 Terumo
13.7.1 Terumo Company Information
13.7.2 Terumo Drug-Eluting Stents Product Portfolios and Specifications
13.7.3 Terumo Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Terumo Main Business Overview
13.7.5 Terumo Latest Developments
13.8 Biosensors International
13.8.1 Biosensors International Company Information
13.8.2 Biosensors International Drug-Eluting Stents Product Portfolios and Specifications
13.8.3 Biosensors International Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biosensors International Main Business Overview
13.8.5 Biosensors International Latest Developments
13.9 Balton
13.9.1 Balton Company Information
13.9.2 Balton Drug-Eluting Stents Product Portfolios and Specifications
13.9.3 Balton Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Balton Main Business Overview
13.9.5 Balton Latest Developments
13.10 AlviMedica Medical Technologies
13.10.1 AlviMedica Medical Technologies Company Information
13.10.2 AlviMedica Medical Technologies Drug-Eluting Stents Product Portfolios and Specifications
13.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AlviMedica Medical Technologies Main Business Overview
13.10.5 AlviMedica Medical Technologies Latest Developments
13.11 Biotronik
13.11.1 Biotronik Company Information
13.11.2 Biotronik Drug-Eluting Stents Product Portfolios and Specifications
13.11.3 Biotronik Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biotronik Main Business Overview
13.11.5 Biotronik Latest Developments
13.12 Shandong JW Medical
13.12.1 Shandong JW Medical Company Information
13.12.2 Shandong JW Medical Drug-Eluting Stents Product Portfolios and Specifications
13.12.3 Shandong JW Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shandong JW Medical Main Business Overview
13.12.5 Shandong JW Medical Latest Developments
13.13 Sino Medical
13.13.1 Sino Medical Company Information
13.13.2 Sino Medical Drug-Eluting Stents Product Portfolios and Specifications
13.13.3 Sino Medical Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sino Medical Main Business Overview
13.13.5 Sino Medical Latest Developments
13.14 Beijing AMSINO
13.14.1 Beijing AMSINO Company Information
13.14.2 Beijing AMSINO Drug-Eluting Stents Product Portfolios and Specifications
13.14.3 Beijing AMSINO Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Beijing AMSINO Main Business Overview
13.14.5 Beijing AMSINO Latest Developments
13.15 Liaoning Biomedical Materials R&D Center Co.(LBC)
13.15.1 Liaoning Biomedical Materials R&D Center Co.(LBC) Company Information
13.15.2 Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Product Portfolios and Specifications
13.15.3 Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Liaoning Biomedical Materials R&D Center Co.(LBC) Main Business Overview
13.15.5 Liaoning Biomedical Materials R&D Center Co.(LBC) Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Drug-Eluting Stents Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug-Eluting Stents Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Rapamycin
Table 4. Major Players of Paclitaxel
Table 5. Major Players of Everolimus
Table 6. Major Players of Others
Table 7. Global Drug-Eluting Stents Sales by Type (2018-2023) & (K Units)
Table 8. Global Drug-Eluting Stents Sales Market Share by Type (2018-2023)
Table 9. Global Drug-Eluting Stents Revenue by Type (2018-2023) & ($ million)
Table 10. Global Drug-Eluting Stents Revenue Market Share by Type (2018-2023)
Table 11. Global Drug-Eluting Stents Sale Price by Type (2018-2023) & (USD/Unit)
Table 12. Global Drug-Eluting Stents Sales by Application (2018-2023) & (K Units)
Table 13. Global Drug-Eluting Stents Sales Market Share by Application (2018-2023)
Table 14. Global Drug-Eluting Stents Revenue by Application (2018-2023)
Table 15. Global Drug-Eluting Stents Revenue Market Share by Application (2018-2023)
Table 16. Global Drug-Eluting Stents Sale Price by Application (2018-2023) & (USD/Unit)
Table 17. Global Drug-Eluting Stents Sales by Company (2018-2023) & (K Units)
Table 18. Global Drug-Eluting Stents Sales Market Share by Company (2018-2023)
Table 19. Global Drug-Eluting Stents Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Drug-Eluting Stents Revenue Market Share by Company (2018-2023)
Table 21. Global Drug-Eluting Stents Sale Price by Company (2018-2023) & (USD/Unit)
Table 22. Key Manufacturers Drug-Eluting Stents Producing Area Distribution and Sales Area
Table 23. Players Drug-Eluting Stents Products Offered
Table 24. Drug-Eluting Stents Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Drug-Eluting Stents Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Drug-Eluting Stents Sales Market Share Geographic Region (2018-2023)
Table 29. Global Drug-Eluting Stents Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Drug-Eluting Stents Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Drug-Eluting Stents Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Drug-Eluting Stents Sales Market Share by Country/Region (2018-2023)
Table 33. Global Drug-Eluting Stents Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Drug-Eluting Stents Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Drug-Eluting Stents Sales by Country (2018-2023) & (K Units)
Table 36. Americas Drug-Eluting Stents Sales Market Share by Country (2018-2023)
Table 37. Americas Drug-Eluting Stents Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Drug-Eluting Stents Revenue Market Share by Country (2018-2023)
Table 39. Americas Drug-Eluting Stents Sales by Type (2018-2023) & (K Units)
Table 40. Americas Drug-Eluting Stents Sales by Application (2018-2023) & (K Units)
Table 41. APAC Drug-Eluting Stents Sales by Region (2018-2023) & (K Units)
Table 42. APAC Drug-Eluting Stents Sales Market Share by Region (2018-2023)
Table 43. APAC Drug-Eluting Stents Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Drug-Eluting Stents Revenue Market Share by Region (2018-2023)
Table 45. APAC Drug-Eluting Stents Sales by Type (2018-2023) & (K Units)
Table 46. APAC Drug-Eluting Stents Sales by Application (2018-2023) & (K Units)
Table 47. Europe Drug-Eluting Stents Sales by Country (2018-2023) & (K Units)
Table 48. Europe Drug-Eluting Stents Sales Market Share by Country (2018-2023)
Table 49. Europe Drug-Eluting Stents Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Drug-Eluting Stents Revenue Market Share by Country (2018-2023)
Table 51. Europe Drug-Eluting Stents Sales by Type (2018-2023) & (K Units)
Table 52. Europe Drug-Eluting Stents Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Drug-Eluting Stents Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Drug-Eluting Stents Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Drug-Eluting Stents Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Drug-Eluting Stents Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Drug-Eluting Stents Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Drug-Eluting Stents Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Drug-Eluting Stents
Table 60. Key Market Challenges & Risks of Drug-Eluting Stents
Table 61. Key Industry Trends of Drug-Eluting Stents
Table 62. Drug-Eluting Stents Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Drug-Eluting Stents Distributors List
Table 65. Drug-Eluting Stents Customer List
Table 66. Global Drug-Eluting Stents Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Drug-Eluting Stents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Drug-Eluting Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Drug-Eluting Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Drug-Eluting Stents Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Drug-Eluting Stents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Drug-Eluting Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Drug-Eluting Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Drug-Eluting Stents Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Drug-Eluting Stents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Drug-Eluting Stents Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Drug-Eluting Stents Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Drug-Eluting Stents Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Drug-Eluting Stents Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Boston Scientific Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 81. Boston Scientific Drug-Eluting Stents Product Portfolios and Specifications
Table 82. Boston Scientific Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Boston Scientific Main Business
Table 84. Boston Scientific Latest Developments
Table 85. Medtronic, Inc. Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 86. Medtronic, Inc. Drug-Eluting Stents Product Portfolios and Specifications
Table 87. Medtronic, Inc. Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Medtronic, Inc. Main Business
Table 89. Medtronic, Inc. Latest Developments
Table 90. Abbott Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Drug-Eluting Stents Product Portfolios and Specifications
Table 92. Abbott Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Abbott Main Business
Table 94. Abbott Latest Developments
Table 95. Lepu Medical Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 96. Lepu Medical Drug-Eluting Stents Product Portfolios and Specifications
Table 97. Lepu Medical Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Lepu Medical Main Business
Table 99. Lepu Medical Latest Developments
Table 100. MicroPort Scientific Corporation Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 101. MicroPort Scientific Corporation Drug-Eluting Stents Product Portfolios and Specifications
Table 102. MicroPort Scientific Corporation Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. MicroPort Scientific Corporation Main Business
Table 104. MicroPort Scientific Corporation Latest Developments
Table 105. Cook Medical Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 106. Cook Medical Drug-Eluting Stents Product Portfolios and Specifications
Table 107. Cook Medical Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Cook Medical Main Business
Table 109. Cook Medical Latest Developments
Table 110. Terumo Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 111. Terumo Drug-Eluting Stents Product Portfolios and Specifications
Table 112. Terumo Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Terumo Main Business
Table 114. Terumo Latest Developments
Table 115. Biosensors International Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 116. Biosensors International Drug-Eluting Stents Product Portfolios and Specifications
Table 117. Biosensors International Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Biosensors International Main Business
Table 119. Biosensors International Latest Developments
Table 120. Balton Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 121. Balton Drug-Eluting Stents Product Portfolios and Specifications
Table 122. Balton Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Balton Main Business
Table 124. Balton Latest Developments
Table 125. AlviMedica Medical Technologies Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 126. AlviMedica Medical Technologies Drug-Eluting Stents Product Portfolios and Specifications
Table 127. AlviMedica Medical Technologies Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. AlviMedica Medical Technologies Main Business
Table 129. AlviMedica Medical Technologies Latest Developments
Table 130. Biotronik Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 131. Biotronik Drug-Eluting Stents Product Portfolios and Specifications
Table 132. Biotronik Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Biotronik Main Business
Table 134. Biotronik Latest Developments
Table 135. Shandong JW Medical Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 136. Shandong JW Medical Drug-Eluting Stents Product Portfolios and Specifications
Table 137. Shandong JW Medical Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Shandong JW Medical Main Business
Table 139. Shandong JW Medical Latest Developments
Table 140. Sino Medical Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 141. Sino Medical Drug-Eluting Stents Product Portfolios and Specifications
Table 142. Sino Medical Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Sino Medical Main Business
Table 144. Sino Medical Latest Developments
Table 145. Beijing AMSINO Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 146. Beijing AMSINO Drug-Eluting Stents Product Portfolios and Specifications
Table 147. Beijing AMSINO Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Beijing AMSINO Main Business
Table 149. Beijing AMSINO Latest Developments
Table 150. Liaoning Biomedical Materials R&D Center Co.(LBC) Basic Information, Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 151. Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Product Portfolios and Specifications
Table 152. Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Liaoning Biomedical Materials R&D Center Co.(LBC) Main Business
Table 154. Liaoning Biomedical Materials R&D Center Co.(LBC) Latest Developments
List of Figures
Figure 1. Picture of Drug-Eluting Stents
Figure 2. Drug-Eluting Stents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Eluting Stents Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug-Eluting Stents Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug-Eluting Stents Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Rapamycin
Figure 10. Product Picture of Paclitaxel
Figure 11. Product Picture of Everolimus
Figure 12. Product Picture of Others
Figure 13. Global Drug-Eluting Stents Sales Market Share by Type in 2022
Figure 14. Global Drug-Eluting Stents Revenue Market Share by Type (2018-2023)
Figure 15. Drug-Eluting Stents Consumed in Angina Pectoris
Figure 16. Global Drug-Eluting Stents Market: Angina Pectoris (2018-2023) & (K Units)
Figure 17. Drug-Eluting Stents Consumed in Myocardial Infarction
Figure 18. Global Drug-Eluting Stents Market: Myocardial Infarction (2018-2023) & (K Units)
Figure 19. Global Drug-Eluting Stents Sales Market Share by Application (2022)
Figure 20. Global Drug-Eluting Stents Revenue Market Share by Application in 2022
Figure 21. Drug-Eluting Stents Sales Market by Company in 2022 (K Units)
Figure 22. Global Drug-Eluting Stents Sales Market Share by Company in 2022
Figure 23. Drug-Eluting Stents Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Drug-Eluting Stents Revenue Market Share by Company in 2022
Figure 25. Global Drug-Eluting Stents Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Drug-Eluting Stents Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Drug-Eluting Stents Sales 2018-2023 (K Units)
Figure 28. Americas Drug-Eluting Stents Revenue 2018-2023 ($ Millions)
Figure 29. APAC Drug-Eluting Stents Sales 2018-2023 (K Units)
Figure 30. APAC Drug-Eluting Stents Revenue 2018-2023 ($ Millions)
Figure 31. Europe Drug-Eluting Stents Sales 2018-2023 (K Units)
Figure 32. Europe Drug-Eluting Stents Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Drug-Eluting Stents Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Drug-Eluting Stents Revenue 2018-2023 ($ Millions)
Figure 35. Americas Drug-Eluting Stents Sales Market Share by Country in 2022
Figure 36. Americas Drug-Eluting Stents Revenue Market Share by Country in 2022
Figure 37. Americas Drug-Eluting Stents Sales Market Share by Type (2018-2023)
Figure 38. Americas Drug-Eluting Stents Sales Market Share by Application (2018-2023)
Figure 39. United States Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Drug-Eluting Stents Sales Market Share by Region in 2022
Figure 44. APAC Drug-Eluting Stents Revenue Market Share by Regions in 2022
Figure 45. APAC Drug-Eluting Stents Sales Market Share by Type (2018-2023)
Figure 46. APAC Drug-Eluting Stents Sales Market Share by Application (2018-2023)
Figure 47. China Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Drug-Eluting Stents Sales Market Share by Country in 2022
Figure 55. Europe Drug-Eluting Stents Revenue Market Share by Country in 2022
Figure 56. Europe Drug-Eluting Stents Sales Market Share by Type (2018-2023)
Figure 57. Europe Drug-Eluting Stents Sales Market Share by Application (2018-2023)
Figure 58. Germany Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Drug-Eluting Stents Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Drug-Eluting Stents Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Drug-Eluting Stents Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Drug-Eluting Stents Sales Market Share by Application (2018-2023)
Figure 67. Egypt Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Drug-Eluting Stents Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Drug-Eluting Stents in 2022
Figure 73. Manufacturing Process Analysis of Drug-Eluting Stents
Figure 74. Industry Chain Structure of Drug-Eluting Stents
Figure 75. Channels of Distribution
Figure 76. Global Drug-Eluting Stents Sales Market Forecast by Region (2024-2029)
Figure 77. Global Drug-Eluting Stents Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Drug-Eluting Stents Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Drug-Eluting Stents Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Drug-Eluting Stents Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Drug-Eluting Stents Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の薬剤溶出性ステント市場予測 2023年-2029年] (コード：LP23MY4580)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の薬剤溶出性ステント市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の薬剤溶出ステント市場予測 2023年-2029年
  • 世界の尿管ステント市場予測 2023年-2029年
  • 世界のダブルJ尿管ステント市場予測 2023年-2029年
  • 世界のバルーン拡張型頭蓋内ステント市場予測 2023年-2029年
  • 世界の頸動脈ステント市場予測 2023年-2029年
  • 世界の冠動脈ステント装置市場予測 2023年-2029年
  • 世界の冠状動脈ステント装置市場予測 2023年-2029年
  • 世界の先進的非経口薬物送達装置市場予測 2023年-2029年
  • 世界の創薬用クロマトグラフィー樹脂市場予測 2023年-2029年
  • 世界の気道ステント＆肺ステント市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆